Mark D.P. Davis

8.0k total citations
144 papers, 4.5k citations indexed

About

Mark D.P. Davis is a scholar working on Dermatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Mark D.P. Davis has authored 144 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Dermatology, 31 papers in Epidemiology and 29 papers in Pathology and Forensic Medicine. Recurrent topics in Mark D.P. Davis's work include Contact Dermatitis and Allergies (37 papers), Autoimmune Bullous Skin Diseases (24 papers) and Allergic Rhinitis and Sensitization (21 papers). Mark D.P. Davis is often cited by papers focused on Contact Dermatitis and Allergies (37 papers), Autoimmune Bullous Skin Diseases (24 papers) and Allergic Rhinitis and Sensitization (21 papers). Mark D.P. Davis collaborates with scholars based in United States, Denmark and Canada. Mark D.P. Davis's co-authors include Roger H. Weenig, David A. Wetter, W. P. Daniel Su, James A. Yiannias, Patrick R. Dahl, Harold O. Perry, Frank C. Powell, Louise K. Andersen, Rokea A. el‐Azhary and Paola Sandroni and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Gastroenterology.

In The Last Decade

Mark D.P. Davis

140 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D.P. Davis United States 38 2.1k 1.5k 997 718 664 144 4.5k
Francesca Sampogna Italy 41 2.9k 1.4× 824 0.5× 532 0.5× 441 0.6× 719 1.1× 156 5.3k
Salvador Arias‐Santiago Spain 37 2.1k 1.0× 728 0.5× 289 0.3× 884 1.2× 648 1.0× 322 5.3k
Annalisa Patrizi Italy 37 3.0k 1.5× 1.2k 0.8× 632 0.6× 640 0.9× 925 1.4× 470 6.1k
Antonio Torrelo Spain 33 2.6k 1.3× 596 0.4× 932 0.9× 738 1.0× 654 1.0× 305 5.6k
Afsáneh Alavi Canada 38 2.8k 1.4× 1.3k 0.9× 303 0.3× 2.3k 3.2× 300 0.5× 230 5.0k
Anne W. Lucky United States 49 3.3k 1.6× 1.3k 0.8× 467 0.5× 2.6k 3.6× 1.6k 2.4× 224 9.5k
Paolo Amerio Italy 32 1.2k 0.6× 719 0.5× 774 0.8× 274 0.4× 672 1.0× 190 4.0k
Hélio Amante Miot Brazil 33 2.7k 1.3× 858 0.6× 330 0.3× 475 0.7× 282 0.4× 335 4.9k
Young Min Park South Korea 32 1.6k 0.8× 854 0.6× 372 0.4× 311 0.4× 369 0.6× 299 4.1k
Mats Jontell Sweden 37 507 0.2× 440 0.3× 444 0.4× 610 0.8× 402 0.6× 132 4.2k

Countries citing papers authored by Mark D.P. Davis

Since Specialization
Citations

This map shows the geographic impact of Mark D.P. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D.P. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D.P. Davis more than expected).

Fields of papers citing papers by Mark D.P. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D.P. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D.P. Davis. The network helps show where Mark D.P. Davis may publish in the future.

Co-authorship network of co-authors of Mark D.P. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D.P. Davis. A scholar is included among the top collaborators of Mark D.P. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D.P. Davis. Mark D.P. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Parker, Eva Rawlings, Misha Rosenbach, & Mark D.P. Davis. (2025). The Voice of the American Dermatological Association: 2025 Official Policy Statement on Climate Change. Journal of Investigative Dermatology. 145(6). 1251–1256. 1 indexed citations
3.
Davis, Mark D.P., Emma F. Johnson, Margot S. Peters, et al.. (2024). Myelodysplasia cutis and VEXAS syndrome initially diagnosed as histiocytoid Sweet syndrome: A diagnostic pitfall. Journal of Cutaneous Pathology. 51(11). 834–839. 2 indexed citations
4.
Kumar, Anagha, et al.. (2024). Clinical Characteristics and Inciting Agents for Pseudoporphyria: The Mayo Clinic Experience, 1996–2020. Advances in Skin & Wound Care. 37(8). 406–411.
5.
Kumar, Anagha, et al.. (2023). Results of Patch Testing to Botanicals: Review of the Mayo Clinic Experience over 2 Decades (1997–2017). Dermatitis. 35(1). 43–48. 1 indexed citations
6.
Hall, Matthew J., James A. Yiannias, Jill M. Killian, et al.. (2023). Trends in Patch Testing of Black Patients: The Mayo Clinic Decade Experience (January 1, 2011, to December 31, 2020). Dermatitis. 34(2). 113–119. 2 indexed citations
7.
Alavi, Afsáneh, et al.. (2021). Cutaneous Manifestations of Diabetes. Medical Clinics of North America. 105(4). 681–697. 19 indexed citations
8.
Nguyen, Henry, Hafsa Chaudhry, Jill M. Killian, et al.. (2018). Patch Testing to Propylene Glycol: The Mayo Clinic Experience. Dermatitis. 29(4). 200–205. 12 indexed citations
9.
Singh, Abha G., Cynthia S. Crowson, Siddharth Singh, et al.. (2016). Cancer risk in cutaneous lupus erythematosus: a population-based cohort study. Lara D. Veeken. 55(11). 2009–2013. 20 indexed citations
10.
Yadav, Siddhant, Siddharth Singh, Jithinraj Edakkanambeth Varayil, et al.. (2015). Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota. Clinical Gastroenterology and Hepatology. 14(1). 65–70. 50 indexed citations
11.
Andersen, Louise K., Jana Hercogová, Uwe Wollina, & Mark D.P. Davis. (2012). Climate change and skin disease: a review of the English‐language literature. International Journal of Dermatology. 51(6). 656–661. 19 indexed citations
12.
Cook‐Norris, Robert H., et al.. (2011). Pediatric erythromelalgia: A retrospective review of 32 cases evaluated at Mayo Clinic over a 37-year period. Journal of the American Academy of Dermatology. 66(3). 416–423. 42 indexed citations
13.
Wetter, David A., et al.. (2010). Incidence of Dermatomyositis and Clinically Amyopathic Dermatomyositis. Archives of Dermatology. 146(1). 26–26. 215 indexed citations
14.
Scalf, Leigh Ann, Mark D.P. Davis, Audrey L. Rohlinger, & Suzanne M. Connolly. (2009). Photopatch Testing of 182 Patients: A 6-Year Experience at the Mayo Clinic. Dermatitis. 20(1). 44–52. 30 indexed citations
15.
Plager, Douglas A., Mark D.P. Davis, Michael J. Coenen, et al.. (2009). Eosinophil Ribonucleases and Their Cutaneous Lesion-Forming Activity. The Journal of Immunology. 183(6). 4013–4020. 20 indexed citations
16.
Vitiello, Benedetto, Mark D.P. Davis, Laurence L. Greenhill, & Daniel S. Pine. (2006). Blindness of Clinical Evaluators, Parents, and Children in a Placebo-Controlled Trial of Fluvoxamine. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 219–225. 6 indexed citations
17.
Davis, Mark D.P. & Sara A. Farmer. (2006). RESULTS OF PATCH TESTING TO A CORTICOSTEROID SERIES: EXPERIENCE WITH 1000 PATIENTS AT MAYO CLINIC. Dermatitis. 17(2). 102–103.
18.
Gregg, Noël, et al.. (2005). Decoding and Spelling Accommodations for Postsecondary Students Demonstrating Dyslexia--It's More than Processing Speed.. 3(2). 1–17. 12 indexed citations
19.
Davis, Mark D.P., Donna M. Richardson, & Sara A. Farmer. (2005). Low Yield for Extended Reading of Patch Tests with Topical Corticosteroids. Dermatitis. 16(3). 124–124. 2 indexed citations
20.
Comfere, Nneka I., et al.. (2005). Patch-Test Reactions to Thioureas Are Frequently Relevant. Dermatitis. 16(3). 121–123. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026